Capish develops unprecedented tools for visualization and exploration of data, offering customer-specific solutions tailored to meet the complex challenges of clinical research. For more information, please visit https://www.capish.com/

ImmuVia is a biotechnology company pioneering a new class of oncology therapeutics—Cancerlysins™—innovative bispecific antibodies designed to radically improve treatment outcomes while overcoming the limitations of all prior approaches. Our flagship candidate, Cancerlysin IMV-M™, is the first molecule to robustly induce apoptosis in targeted cells without relying on cytotoxic payloads or the internalization of antibody constructs—key limitations of ADCs. As a leader in bispecific antibody development, we are excited to connect with industry experts, researchers, and potential partners at the IO360° Summit 2025. For more information, visit https://immuviatx.com/

To learn more, please visit: https://lifelinepilots.org/

To learn more, visit https://www.labcorp.com/

Angel Flight East provides free flights for patients in need of medical treatment far from home. Volunteer pilots use their own airplanes and cover all costs of the flight. Angel Flight East covers a 14 state footprint, from Virginia to Ohio to Maine. To learn more, please visit: https://angelflighteast.org/

For more information, please visit https://vianautis.com/

Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com.

DALI has been developing drug delivery devices from concept to commercialization for pharmaceutical and medical device companies since 2003. Our injectable drug delivery devices are designed for increased patient compliance to prescribed therapies (by Biologic/Biosimilar/Generic drugs) with greater ease and comfort than ever before. In addition, DALI’s creative and proven injectable drug delivery devices answer patient needs for easy self-administration. For more information please visit https://www.dalimed.com/

For more information please visit https://www.paradigm.inc/

For more information, please visit https://www.danforthadvisors.com/